MARKET

MRVI

MRVI

Maravai Lifesciences Holdings, Inc.
NASDAQ
3.020
-0.100
-3.21%
After Hours: 3.010 -0.01 -0.33% 16:18 02/12 EST
OPEN
3.120
PREV CLOSE
3.120
HIGH
3.170
LOW
2.970
VOLUME
1.05M
TURNOVER
--
52 WEEK HIGH
4.770
52 WEEK LOW
1.665
MARKET CAP
772.23M
P/E (TTM)
-3.5774
1D
5D
1M
3M
1Y
5Y
1D
Press Release: Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
Dow Jones · 3d ago
Maravai LifeSciences Holdings Inc. kündigt Veröffentlichung von Finanzergebnissen an
Reuters · 3d ago
Maravai LifeSciences Holdings Inc. to Announce Financial and Operating Results and Host Earnings Call
Reuters · 3d ago
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
Barchart · 3d ago
Weekly Report: what happened at MRVI last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at MRVI last week (0126-0130)?
Weekly Report · 02/02 09:24
Maravai LifeSciences Holdings (NASDAQ:MRVI shareholders incur further losses as stock declines 11% this week, taking five-year losses to 90%
Simply Wall St · 01/29 10:47
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Maravai Lifesciences Holdings (MRVI)
TipRanks · 01/29 08:40
More
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.

Webull offers Maravai Lifesciences Holdings Inc stock information, including NASDAQ: MRVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRVI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRVI stock methods without spending real money on the virtual paper trading platform.